These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 21636627

  • 1. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
    Plazak W, Gryga K, Milewski M, Podolec M, Kostkiewicz M, Podolec P, Musial J.
    Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
    [Abstract] [Full Text] [Related]

  • 2. Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients.
    Plazak W, Pasowicz M, Kostkiewicz M, Podolec J, Tomkiewicz-Pajak L, Musial J, Podolec P.
    Inflamm Res; 2011 Oct; 60(10):973-80. PubMed ID: 21744266
    [Abstract] [Full Text] [Related]

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 4. Myocardial ischaemia in systemic lupus erythematosus: detection and clinical relevance.
    Płazak W, Gryga K, Sznajd J, Pasowicz M, Musiał J, Podolec P.
    Kardiol Pol; 2011 Dec; 69(11):1129-36. PubMed ID: 22090220
    [Abstract] [Full Text] [Related]

  • 5. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
    Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE.
    Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
    [Abstract] [Full Text] [Related]

  • 6. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O.
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 9. Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy.
    Sella EM, Sato EI, Barbieri A.
    Arthritis Rheum; 2003 Nov; 48(11):3168-75. PubMed ID: 14613279
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 11. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 12. IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.
    Mehrani T, Petri M.
    J Rheumatol; 2011 Mar; 38(3):450-3. PubMed ID: 21123325
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 14. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 15. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 16. [Echocardiographic changes and anticardiolipin antibodies in patients with systemic lupus erythematosus].
    Zhang SD, Wu M, Chen F, Zuo XX, Zhang J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):692-5. PubMed ID: 17062932
    [Abstract] [Full Text] [Related]

  • 17. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 18. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 19. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N.
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [Abstract] [Full Text] [Related]

  • 20. Myocardial Ischaemia, Coronary Atherosclerosis and Pulmonary Pressure Elevation in Antiphospholipid Syndrome Patients.
    Padjas A, Płazak W, Celińska-Lowenhoff M, Mazurek A, Perricone C, Podolec P, Musiał J.
    Adv Clin Exp Med; 2016 Mar; 25(6):1199-1205. PubMed ID: 28028974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.